Use of preparations containing anti-cd44 antibodies for the...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01)

Patent

CA 2281934

The present invention relates to the use of anti-CD44 antibodies from the constant portion (sDC44) and variable portion of CD44 (VCD44) in the treatment of certain tumours and other diseases which are associated with degeneracy and activation of Langerhans cells (LC) and dendritic cells (DC) in the body of a mammal including human beings, and in the treatment of undesirable immune reactions. The invention also relates to an ex vivo culture method for the production of dendritic cells.

L'invention concerne l'utilisation d'anticorps anti-CD44 provenant de la partie constante (sCD44) et de la partie variable (vCD44) du CD44 pour traiter certaines tumeurs et d'autres maladies associées à une dégénérescence et à une activation des cellules de Langerhans (LC) et des cellules dendritiques (DC) d'un organisme de mammifère, y compris l'homme, ainsi que pour traiter des réactions immunitaires indésirables. L'invention concerne également une technique de culture ex vivo permettant de produire des cellules dendritiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of preparations containing anti-cd44 antibodies for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of preparations containing anti-cd44 antibodies for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of preparations containing anti-cd44 antibodies for the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2052720

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.